CMB.TECH 16.100 € (+3,21 %) RECTICEL 13.840 € (+8,12 %) VGP 81.400 € (+0,99 %) BARCO 7.955 € (+1,86 %) NYXOAH 1.410 € (-0,70 %) ARGENX SE 900.400 € (-0,77 %) VIOHALCO 16.820 € (-0,71 %) CARE PROPERTY INV. 12.160 € (0,00 %) MONTEA 65.600 € (-0,46 %) UMICORE 23.840 € (+1,79 %) UCB 217.000 € (-2,21 %) AB INBEV 68.360 € (+1,64 %) D'IETEREN GROUP 176.600 € (+1,49 %) BEKAERT 38.450 € (-0,13 %) CENERGY 22.840 € (+0,35 %) TESSENDERLO 23.450 € (-1,68 %) SOLVAY 25.800 € (+1,57 %) AGEAS 74.700 € (+1,36 %) WDP 21.360 € (+0,47 %) CIE BOIS SAUVAGE 294.000 € (0,00 %) KBC 132.750 € (+0,84 %) XIOR 27.150 € (+0,93 %) TITAN S.A. 53.700 € (+1,90 %) ORANGE BELGIUM 22.000 € (0,00 %) ACKERMANS V.HAAREN 278.600 € (+7,98 %) TUBIZE-FIN 187.700 € (-1,57 %) BREDERODE 103.600 € (0,00 %) DEME GROUP 178.000 € (-1,11 %) KBC ANCORA 94.500 € (+0,85 %) KINEPOLIS GROUP 46.200 € (+1,09 %) AZELIS GROUP 12.270 € (+2,25 %) ASCENCIO 51.700 € (0,00 %) FLUXYS BELGIUM D 22.500 € (+1,35 %) GBL 74.050 € (+1,16 %) MELEXIS 65.750 € (-0,38 %) BPOST 1.310 € (+2,34 %) AEDIFICA 68.150 € (-0,29 %) IMMOBEL 20.500 € (-2,38 %) SHURGARD 23.250 € (0,00 %) ONTEX GROUP 2.825 € (+0,71 %) LOTUS BAKERIES 12 840.000 € (-1,08 %) SYENSQO 81.300 € (+2,01 %) PROXIMUS 6.300 € (-0,16 %) HOME INVEST BE. 18.840 € (-0,32 %) EVS 30.300 € (+0,66 %) ONWARD MEDICAL 2.445 € (+5,84 %) CFE 11.400 € (0,00 %) DECEUNINCK 2.430 € (-0,82 %) GIMV 44.500 € (+1,25 %) SIPEF 103.600 € (+1,37 %) FAGRON 22.550 € (+0,22 %) ELIA GROUP 128.800 € (+1,66 %) BANIMMO A 3.060 € (-0,65 %) VASTNED 28.500 € (0,00 %) INCLUSIO SA/NV 17.300 € (+1,76 %) SOLVAC NOM(RETAIL) 82.000 € (-2,38 %) SOFINA 249.200 € (+0,97 %) BQUE NAT. BELGIQUE 377.000 € (-1,31 %) QRF 10.300 € (+2,49 %) ACCENTIS 0.026 € (-1,89 %)
CVC CAPITAL 14.830 € (+0,54 %)
ATON 0.016 € (-3,61 %)
MAUNA KEA TECH 0.160 € (+2,82 %)
AYVENS 10.970 € (+0,64 %)
EMEIS 12.770 € (+0,87 %)
TOTALENERGIES 74.650 € (+0,65 %)
ING GROEP N.V. 30.305 € (+0,60 %)
BE SEMICONDUCTOR 198.450 € (+1,77 %)
UNIBAIL-RODAMCO-WE 98.680 € (-0,54 %)
SHELL PLC 39.005 € (+0,63 %)
CAPGEMINI 108.600 € (-0,82 %)
AHOLD DEL 30.560 € (0,00 %)
ASM INTERNATIONAL 827.600 € (+0,02 %)
BOUYGUES 43.860 € (-0,30 %)
SOCIETE GENERALE 72.190 € (+1,63 %)
NN GROUP 77.900 € (+0,85 %)
AIR LIQUIDE 170.020 € (+1,94 %)
PHILIPS KON 23.120 € (-0,43 %)
EXOR NV 73.050 € (+1,81 %)
ABN AMRO BANK N.V. 41.390 € (+1,30 %)
DSM FIRMENICH AG 95.840 € (+2,37 %)
STMICROELECTRONICS 43.400 € (-0,42 %)
EUROFINS SCIENT. 72.900 € (-0,14 %)
MAGNUM 17.392 € (+0,40 %)
ADYEN 1 088.000 € (+0,78 %)
PROSUS 38.340 € (+0,87 %)
UNILEVER 55.960 € (+0,77 %)
DASSAULT SYSTEMES 23.050 € (-0,09 %)
KPN KON 4.106 € (+0,51 %)
SBM OFFSHORE 34.160 € (+0,41 %)
ASR NEDERLAND 71.980 € (+1,72 %)
ARCELORMITTAL SA 64.420 € (+0,81 %)
AKZO NOBEL 61.800 € (+0,46 %)
LEGRAND 140.550 € (+3,04 %)
UMG 14.880 € (+0,17 %)
HEINEKEN 72.580 € (+0,61 %)
GTT 211.200 € (+1,54 %)
AALBERTS NV 43.700 € (+0,37 %)
INPOST 15.520 € (0,00 %)
RELX 31.140 € (-0,32 %)
ASML HOLDING 1 485.200 € (-0,08 %)
IMCD 99.400 € (+2,73 %)
WOLTERS KLUWER 69.940 € (-0,26 %)
AEGON 7.998 € (+1,37 %)
SCHNEIDER ELECTRIC 301.600 € (+1,36 %)
SOITEC 108.950 € (-1,40 %)
THEON INTERNAT 33.700 € (-0,88 %)
VEOLIA ENVIRON. 32.870 € (+0,89 %)
STELLANTIS NV 4.678 € (+2,30 %)
L'OREAL 390.000 € (+1,34 %)
MOTA ENGIL 4.862 € (+0,87 %)
ADP 109.500 € (-1,79 %)
SANOFI 77.070 € (-0,27 %)
RENAULT 29.260 € (+3,03 %)
CREDIT AGRICOLE 18.363 € (+0,59 %)
ADVICENNE 1.756 € (+3,17 %)
Vusion 130.400 € (+1,88 %)
ACCOR 46.680 € (+0,06 %)
PERNOD RICARD 63.760 € (-1,15 %)
ORANGE 15.165 € (+0,43 %) News Réglementées
|
27/08/2026 07:30
Fielmann Group AG: Half-Year Financial Report as at June 30, 2026EQS-News: Fielmann Group AG / Key word(s): Half Year Report
Dear shareholders and friends of the company, In the first half of 2026, the Fielmann Group once again demonstrated the resilience of its business model in a challenging market environment. While growth in Germany remained temporarily subdued, the Group benefited from its diversified country portfolio as strong momentum across international markets supported the overall growth of the Group. The US business made further progress during the first half of 2026. Growth in local currency accelerated, supported by continued investments in the platform, operational improvements and expanding doctor capacity. In addition, foreign exchange headwinds eased in Q2 compared to Q1. Macroeconomic conditions varied across the Group's markets. While subdued consumer sentiment continued to weigh on Germany, economic conditions in several international markets remained more supportive. Against this backdrop, the Group maintained a robust profitability profile, reflecting its disciplined cost management while investing in its long-term growth ambitions. Looking ahead, the Fielmann Group is well positioned for stronger growth in the second half of the year. New store openings, productivity initiatives and targeted hiring are expected to expand the Group's capacity to serve more customers and support the continued execution of Vision 2035. Additional features: File: Fielmann Group AG HY1 2026 EN s 27.08.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
2389258 27.08.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||||||
© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière